gC1q-R, Human, mAb 74.5.2 – 500 µg

gC1q-R, Human, mAb 74.5.2 – 500 µg

Antibodies Primary

Article No

182-HM2015-500UG

Species Reactivity

human

Size

500 µg

Clone

74.5.2

Source / Host

mouse

Shipping Information

Room Temperature

Application

FC, FS, IA, IP, WB

Article No

182-HM2015-500UG

Species Reactivity

human

Size

500 µg

Clone

74.5.2

Source / Host

mouse

Shipping Information

Room Temperature

Application

FC, FS, IA, IP, WB

Specifications

Application FC, FS, IA, IP, WB
Article No 182-HM2015-500UG
Country Availability SE, FI, DK, NO, EE, LV, LT
Clone 74.5.2
Clone Type monoclonal
Conjugation Unconjugated
Description gC1q-R, Human, mAb 74.5.2 – 500 µg
Supplier Hycult biotechnology
Immunogen Recombinant-gC1qR corresponding to maturegC1qR (amino acids 74-282)
Isotype IgG1
Notes The monoclonal antibody 74.5.2 recognizes a cell membrane C1q binding molecule that recognises the globular heads of C1q. It is also present in plasma and the extracellular matrix. The molecule is an unusually acidic, single chain protein with an apparent molecular weight of 33 kDa. It does not possess a conventional sequence motif compatible with a membrane spanning segment nor a consensus site for a GPI anchor. gC1q-R migrates as a single chain under both reducing and non-reducing conditions, but it behaves as an oligomer on gel-filtration in non-dissociating conditions. Its multimer formation may be a critical process by which the gC1q-R molecule increases its affinity for multivalent ligands such as C1q. gC1q-R has been shown to inhibit complement activation by preventing the binding of C1q to antibodies, suggesting that the binding site for gC1q-R and the binding site for immune complexes, which are present on the C1q globular ‘heads’, may be located at the same position. gC1q-R is capable of interacting with several proteins involved in blood clotting, namely, thrombin, prothrombin, the heparinbinding form of vitronectin, the ternary complex, vitronectin-thrombin-antithrombin, as well as high-molecular-weight kininogen and Hageman factor. Besides its role in the complement pathway, gC1q-R participates in enhancement of Fc-receptor and CR1-mediated phagocytosis, procoagulant activity on platelets, and chemotactic activity on mast cells, eosinophils, neutrophils, and fibroblasts. gC1q-R is expressed on a wide variety of cells and can serve as a binding site for plasma and microbial proteins. Its antigenic sites may be cryptic on cells in suspension but become exposed when the cells are fixed by bifunctional cross-linkers. Probably it is also expressed on the cell membrane as a tetramer. Crosslinking or activation may thus bring about a tetrameric assembly of gC1q-R followed by a conformational change within the molecule, thereby exposing epitopes which are otherwise hidden. A form of gC1q-R is also found inside the cell. Intracellular gC1q-R has been shown to bind the cytoplasmic tail of the α1B-adrenergic receptor and to PKCμ. The monoclonal antibody 74.5.2 is directed against epitopes in the XC15 peptide that contains a binding site for high-molecular-weight kininogen and Factor XII. Clone 74.5.2 recognizes both the mature (74 – 282) and truncated form, lacking residues 74-95.
Alias Names Complement component 1 Q subcomponent-binding protein, mitochondrial, ASF/SF2-associated protein p32, Glycoprotein gC1qBP, C1qBP, Hyaluronan-binding protein 1, Mitochondrial matrix protein p32, p33 Gene name: C1QBP, GC1QBP, HABP1, SF2P32
Previous Article No HM2015-FS, 182-HM2015-500UG, HM2015-500UG
Product Type Antibodies Primary
Research area Immunology
Shipping Information Room Temperature
Size 500 µg
Source / Host mouse
Species Reactivity human
Storage no_selection
Substrate / Buffer Quantities >500 µg will be send without preservative and carrier free. Quantities
Product Page Updated 2024-04-05T09:42:44.568Z

References

Show more
Shipping info
The delivery time for this item is approximately 5-8 business days. Read more